ID

17306

Beschreibung

Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00605111

Link

https://clinicaltrials.gov/show/NCT00605111

Stichworte

  1. 06.09.16 06.09.16 -
Hochgeladen am

6. September 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes NCT00605111

Eligibility Diabetes NCT00605111

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00605111
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes for at least 24 months
Beschreibung

Non-Insulin-Dependent Diabetes Mellitus disease length

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
bmi between 18 and 30 kg/m2
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
insulin naive subjects
Beschreibung

Insulin Therapy naive

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0919936
oad treatment with max two oads alone or combined with other therapy
Beschreibung

Oral hypoglycemic Quantity | Combined Modality Therapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0359086
UMLS CUI [1,2]
C1265611
UMLS CUI [2]
C0009429
hba1c between 7-12%
Beschreibung

Glycosylated hemoglobin A

Datentyp

boolean

Alias
UMLS CUI [1]
C0019018
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 diabetes
Beschreibung

Diabetes Mellitus, Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011854
receipt of any investigational drug within the last three months prior to this trial
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
current or previous treatment with thiazolidiones within the last 6 months
Beschreibung

Thiazolidinediones

Datentyp

boolean

Alias
UMLS CUI [1]
C1257987
oad treatment with three or more oads within the last 4 months
Beschreibung

Oral hypoglycemic Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0359086
UMLS CUI [1,2]
C1265611

Ähnliche Modelle

Eligibility Diabetes NCT00605111

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00605111
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus disease length
Item
type 2 diabetes for at least 24 months
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Body mass index
Item
bmi between 18 and 30 kg/m2
boolean
C1305855 (UMLS CUI [1])
Insulin Therapy naive
Item
insulin naive subjects
boolean
C0021641 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
Oral hypoglycemic Quantity | Combined Modality Therapy
Item
oad treatment with max two oads alone or combined with other therapy
boolean
C0359086 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0009429 (UMLS CUI [2])
Glycosylated hemoglobin A
Item
hba1c between 7-12%
boolean
C0019018 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Investigational New Drugs
Item
receipt of any investigational drug within the last three months prior to this trial
boolean
C0013230 (UMLS CUI [1])
Thiazolidinediones
Item
current or previous treatment with thiazolidiones within the last 6 months
boolean
C1257987 (UMLS CUI [1])
Oral hypoglycemic Quantity
Item
oad treatment with three or more oads within the last 4 months
boolean
C0359086 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video